Showing results (371-380 of 699) with videos related to

Sort By:
Pageof 70
International Journal of Cardiology|July 17, 2016
Impact of type 2 diabetes and duration of type 2 diabetes on cardiac structure and functionPeter G Jørgensen, Magnus T Jensen, Rasmus Mogelvang, et al.
The New England Journal of Medicine|August 27, 2021
Cardiovascular Events with Finerenone in Kidney Disease and Type 2 DiabetesBertram Pitt, Gerasimos Filippatos, Rajiv Agarwal, et al.
European Heart Journal|January 13, 2022
Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysisRajiv Agarwal, Gerasimos Filippatos, Bertram Pitt, et al.
Heliyon|January 3, 2023
Increased mitochondrial proton leak and glycolysis in peripheral blood mononuclear cells in type-1-diabetesJoana Mendes Lopes de Melo, Jens Christian Laursen, Niels Søndergaard-Heinrich, et al.
Diabetologia|March 23, 2019
Correction to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)Melanie J Davies, David A D'Alessio, Judith Fradkin, et al.
Diabetologia|October 6, 2018
Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)Melanie J Davies, David A D'Alessio, Judith Fradkin, et al.
Diabetes Care|October 7, 2018
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)Melanie J Davies, David A D'Alessio, Judith Fradkin, et al.
Circulation|November 17, 2020
Finerenone and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Type 2 DiabetesGerasimos Filippatos, Stefan D Anker, Rajiv Agarwal, et al.
The New England Journal of Medicine|December 2, 2020
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 DiabetesGeorge L Bakris, Rajiv Agarwal, Stefan D Anker, et al.
Circulation|November 15, 2021
Finerenone Reduces Risk of Incident Heart Failure in Patients With Chronic Kidney Disease and Type 2 Diabetes: Analyses From the FIGARO-DKD TrialGerasimos Filippatos, Stefan D Anker, Rajiv Agarwal, et al.
Pageof 70